Abuse Deterrence

Whether intentional or unintentional, the abuse of particular drugs can be potentially life threatening. The FDA suggests that by 2020, all narcotics will require some type of abuse deterrence technology to be commercialized and approved for sales in the US.

To address the health and regulatory needs, Dow offers a broad range of chemistry for abuse deterrence applications. POLYOX™, a high molecular poly(ethylene oxide), is the leading, recognized technology in this space and provides tamper resistant properties. In addition, the ion exchange resins AMBERLITE™ and DUOLITE™ can bind the active pharmaceutical ingredient (API) to prevent immediate release.

Solutions for Abuse Deterrence